Trial Profile
A Phase II, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of topical lidocaine spray in patients with Postherpetic Neuralgia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jan 2020
Price :
$35
*
At a glance
- Drugs Lidocaine (Primary)
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Andros Pharmaceuticals
- 29 Jan 2020 Status changed from recruiting to completed.
- 22 Aug 2018 New trial record